Furthermore, combining GAL (1–15) with the antidepressant escitalopram (ESC) not only reduced alcohol self-administration but also mitigated ESC-induced adverse effects in depression-related behavioral tests (Cantero-García et al., 2022b). This evidence concerns the gene GAL and depressive symptom measurement.